WaferGen Turns First Quarterly Profit on SmartChip Early-Access Sales
August 19, 2010
WaferGen Turns First Quarterly Profit on SmartChip Early-Access Sales
On the heels of the full commercial launch of its SmartChip real-time PCR system earlier this month, WaferGen said that its revenues for the second quarter of 2010 grew by more than 500 percent year over year and nearly 10 percent sequentially due to early-access sales of the platform.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- WaferGen Betting that New NGS Target-Enrichment Workflow Can Help Drive SmartChip Uptake
January 10, 2013 / PCR Insider - WaferGen's Q2 Revenues Drop 10-Fold Due to Dearth of SmartChip Sales
September 15, 2011 / PCR Insider - WaferGen Announces Full Commercial Launch of SmartChip Real-Time PCR System
August 5, 2010 / PCR Insider - WaferGen Reports Spike in Q1 Revenues from SmartChip Early-Access Sales
May 20, 2010 / PCR Insider - Wafergen Cash Reserves Dwindling as it Preps SmartChip for Market
April 29, 2010 / PCR Insider